← Leaderboards
Sidharth Venkata Puram
Washington University
$4,377,910
Attributed
$6,169,328
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,169,328 · 7
By mechanism
R01$2,977,188 · 2
U01$1,341,774 · 2
K08$984,116 · 1
R21$866,250 · 2
Top collaborators
- Robi D Mitra5 shared
- Shama Virani3 shared
- Shannon L Stott1 shared
Most similar at Washington University
Same institution · by research overlap
- Ramaswamy Govindan$14,816,161
- Alex Taylor Ramsey$4,405,661
- Sanjay Jain$27,367,157
- Yong Wang$8,889,709
- Li-Shiun Chen$7,324,917
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorCellsHead And Neck Squamous Cell CarcinomaMesenchymalMortalityHead And Neck CancerNeoplasm MetastasisGenetic TranscriptionGenesTranscriptome SequencingPathway InteractionsCell LineMalignant NeoplasmsHeterogeneityMorbidity - Disease RateTumor HeterogeneityNeoplastic CellSmall MoleculeIn VivoIn VitroSingle-Cell Rna SequencingExperimental StudyMass Spectrum AnalysisPrograms
Grant awards (19)
Validating the hybrid epithelial/mesenchymal state as a biomarker of treatment response and outcomes in head and neck cancer$702,871
U01 · FY2025 · DE · contact PI
Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer$606,038
R01 · FY2025 · DE · contact PI
Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data$534,915
U01 · FY2025 · DE · contact PI
Dissecting hybrid epithelial-mesenchymal states in head and neck cancer$393,750
R01 · FY2025 · DE · contact PI
Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data$75,000
U01 · FY2025 · DE · contact PI
Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data$28,988
U01 · FY2025 · DE · contact PI
Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer$593,918
R01 · FY2024 · DE · contact PI
Dissecting hybrid epithelial-mesenchymal states in head and neck cancer$383,834
R01 · FY2024 · DE · contact PI
Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer$607,981
R01 · FY2023 · DE · contact PI
Dissecting hybrid epithelial-mesenchymal states in head and neck cancer$391,667
R01 · FY2023 · DE · contact PI
Understanding programs of invasion and metastasis in head and neck cancer$163,864
K08 · FY2023 · CA · contact PI
An inducible molecular memory system to unravel the mechanisms of drug resistance in head and neck cancer$157,500
R21 · FY2023 · DE · contact PI
An inducible molecular memory system to unravel the mechanisms of drug resistance in head and neck cancer$275,625
R21 · FY2022 · DE · contact PI
RNA modification and the regulation of partial EMT in head and neck cancer$236,250
R21 · FY2022 · DE · contact PI
Understanding programs of invasion and metastasis in head and neck cancer$163,864
K08 · FY2022 · CA · contact PI
Understanding programs of invasion and metastasis in head and neck cancer$218,796
K08 · FY2021 · CA · contact PI
RNA modification and the regulation of partial EMT in head and neck cancer$196,875
R21 · FY2021 · DE · contact PI
Understanding programs of invasion and metastasis in head and neck cancer$218,796
K08 · FY2020 · CA · contact PI
Understanding programs of invasion and metastasis in head and neck cancer$218,796
K08 · FY2019 · CA · contact PI